Results 21 to 30 of about 2,041,012 (194)
Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives. [PDF]
World J Hepatol, 2015 Transarterial radioembolization (TARE) is a form of brachytherapy in which intra-arterially injected yttrium-90-loaded microspheres serve as a source for internal radiation purposes. On the average, it produces disease control rates exceeding 80% and it is a consolidated therapy for hepatocellular carcinoma (HCC); however, current data are all based on
Mosconi C +3 more
europepmc +4 more sources
Yttrium-90 microsphere induced gastrointestinal tract ulceration [PDF]
World Journal of Surgical Oncology, 2008 Abstract Background Radiomicrosphere therapy (RT) utilizing yttrium-90 (90Y) microspheres has been shown to be an effective regional treatment for primary and secondary hepatic malignancies. We sought to determine a large academic institution's experience regarding the extent and frequency of gastrointestinal ...
Rikabi Ali A +7 more
openaire +3 more sources
Predictive SIRT dosimetry based on a territorial model
EJNMMI Physics, 2017 Background In the planning of selective internal radiation therapy (SIRT) for liver cancer treatment, one major aspect is to determine the prescribed activity and to estimate the resulting absorbed dose inside normal liver and tumor tissue.
Nadine Spahr +4 more
doaj +1 more source
Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma
Liver Cancer, 2014 Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile.
Edeline, Julien +4 more
openaire +3 more sources
Radiology and Oncology, 2020 The aim of the study was to evaluate the safety and feasibility of intra-arterial mitomycin C (MMC) infusion after selective internal radiation therapy (SIRT) using Yttrium-90 (90Y) resin microspheres in liver metastatic breast cancer (LMBC) patients.
Aarts Brigitte Maximiliana +8 more
doaj +1 more source
Planning Arteriography for Yttrium-90 Microsphere Radioembolization [PDF]
Seminars in Interventional Radiology, 2015 Yttrium-90 radioembolization (Y RE) is a contemporary transcatheter locoregional therapy for primary and secondary hepatic malignancies that is commonly utilized in modern Interventional Radiology (IR) practice.1 Unlike other targeted endovascular therapies, such as transarterial chemoembolization (TACE) and transarterial embolization (TAE), the ...
openaire +2 more sources
Scientific Reports, 2022 While radioembolization with yttrium-90 (Y-90) microspheres is a promising treatment for hepatocellular carcinoma (HCC), lower responses in advanced and high-grade tumors present an urgent need to augment its tumoricidal efficacy.
Christopher D. Malone +7 more
doaj +1 more source
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y microspheres [PDF]
Clinical and Molecular Hepatology, 2014 Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma.
Sun Young Yim +10 more
doaj +1 more source
Liver Radioembolization: a New Chapter in Russian Oncology
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2019 Recent years have seen an increase in the number of patients with malignant tumours of the liver. In this context, new treatment methods are being actively introduced into practice, one of which is liver radioembolization utilizing microspheres embedded ...
A. D. Kaprin +12 more
doaj +1 more source
World Journal of Nuclear Medicine, 2013 Locoregional treatment of hepatocellular carcinomas using yttrium-90 (Y-90) microspheres is an emerging modality, and involves the administration of such radioactive particles directly into the hepatic arterial vasculature.
Andrew Eik Hock Tan +2 more
doaj +1 more source